9 results
10-K
2020 FY
NEXI
Neximmune Inc
31 Mar 21
Annual report
4:02pm
and potential approval of our product candidates in our current pipeline, we expect to continue to innovate and potentially expand our portfolio. Because we
424B4
NEXI
Neximmune Inc
16 Feb 21
Prospectus supplement with pricing info
4:38pm
, we expect to continue to innovate and potentially expand our portfolio. Because we have limited financial and managerial resources, research programs
S-1/A
mb9yb
8 Feb 21
IPO registration (amended)
7:29am
S-1
biti9h376l
19 Jan 21
IPO registration
4:38pm
DRS/A
r51fnq cralubf
15 Jan 21
Draft registration statement (amended)
12:00am
DRS
87l9t 9mx6jo
14 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next